CLX vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Clorox Company presents as a classic value trap, characterized by a stable Piotroski F-Score of 5/9 but severely undermined by a massive valuation gap, with a current price of $98.68 far exceeding its growth-based intrinsic value of $42.77. Financial health is concerning due to critical liquidity shortages, evidenced by a Quick Ratio of 0.38 and a Current Ratio of 0.74. Negative year-over-year revenue (-0.80%) and earnings (-16.20%) growth, combined with a 0/100 technical trend, indicate a strong bearish momentum. While the 5.03% dividend is attractive, the 80.52% payout ratio is increasingly risky given the declining earnings trajectory.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
CLX vs PG: Head-to-Head Comparison
This page compares The Clorox Company (CLX) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.